These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34322975)

  • 1. Lower seroprevalence for SARS-CoV-2-specific antibodies among kidney transplant recipients compared to the general population in the city of Sao Paulo, Brazil.
    Cristelli MP; Viana LA; Fortaleza CM; Granato C; Nakamura MR; Santos DWCL; Foresto RD; Tedesco-Silva H; Medina-Pestana J
    Transpl Infect Dis; 2021 Oct; 23(5):e13706. PubMed ID: 34322975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of initial SARS-CoV-2 seroprevalence in the most affected districts in the municipality of São Paulo, Brazil.
    Tess BH; Granato CFH; Alves MCGP; Pintão MCT; Nunes MC; Rizzatti EG; Reinach FC
    Braz J Infect Dis; 2021; 25(4):101604. PubMed ID: 34416142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of SARS-CoV-2 in Croatian solid-organ transplant recipients.
    Mrzljak A; Jureković Ž; Pavičić-Šarić J; Stevanović V; Tabain I; Hruškar Ž; Mikulić D; Barbić L; Vilibić-Čavlek T
    Biochem Med (Zagreb); 2021 Oct; 31(3):030901. PubMed ID: 34658649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral response to SARS-CoV-2 is well preserved and symptom dependent in kidney transplant recipients.
    Magicova M; Fialova M; Zahradka I; Rajnochova-Bloudickova S; Hackajlo D; Raska P; Striz I; Viklicky O
    Am J Transplant; 2021 Dec; 21(12):3926-3935. PubMed ID: 34212497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of SARS-CoV-2 spike IgG antibodies after the second BNT162b2 mRNA vaccine in Japanese kidney transplant recipients.
    Hamaya T; Hatakeyama S; Yoneyama T; Tobisawa Y; Kodama H; Fujita T; Murakami R; Fujita N; Okamoto T; Yamamoto H; Yoneyama T; Hashimoto Y; Saitoh H; Narumi S; Tomita H; Ohyama C
    Sci Rep; 2022 Apr; 12(1):5876. PubMed ID: 35393481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low seroprevalence of SARS-CoV-2 antibodies in a liver transplant cohort.
    Campos-Varela I; Len O; Villagrasa A; Márquez-Algaba E; Esperalba J; Dopazo C; Los-Arcos I; Antón A; Castells L
    Transpl Int; 2021 Oct; 34(10):1908-1913. PubMed ID: 34121244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High anti-SARS-CoV-2 antibody seroconversion rates before the second wave in Manaus, Brazil, and the protective effect of social behaviour measures: results from the prospective DETECTCoV-19 cohort.
    Lalwani P; Araujo-Castillo RV; Ganoza CA; Salgado BB; Pereira Filho IV; da Silva DSS; de Morais TBDN; Jordão MF; Ortiz JV; Barbosa ARC; Sobrinho WBS; Cordeiro IB; de Souza Neto JN; de Assunção EN; da Costa CF; de Souza PE; de Albuquerque BC; Astofi-Filho S; ; Lalwani JDB
    Lancet Glob Health; 2021 Nov; 9(11):e1508-e1516. PubMed ID: 34678195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing rate of anti-SARS-CoV-2 antibodies between the first and second waves of COVID-19 in São Paulo, Brazil: A cross-sectional blood donors-based study.
    Moya Rios do Vale N; Roche Moreira Latini F; Prisco Arnoni C; Martins Parreira R; Batista Castelo Girão MJ; Pereira Cortez AJ; Carvalho de Souza Bonetti T
    Clinics (Sao Paulo); 2022; 77():100016. PubMed ID: 35272203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Peru in July and August, 2020: a population-based study.
    Álvarez-Antonio C; Meza-Sánchez G; Calampa C; Casanova W; Carey C; Alava F; Rodríguez-Ferrucci H; Quispe AM
    Lancet Glob Health; 2021 Jul; 9(7):e925-e931. PubMed ID: 34022148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral immunity of BBIBP-CorV (Sinopharm) in kidney transplant recipients: Is it time to revise vaccination strategies.
    Nafar M; Chehrazi S; Dalili N; Firouzan A; Poorrezagholi F; Samadian F; Samavat S
    Transpl Infect Dis; 2022 Apr; 24(2):e13798. PubMed ID: 35061293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys.
    Hallal PC; Hartwig FP; Horta BL; Silveira MF; Struchiner CJ; Vidaletti LP; Neumann NA; Pellanda LC; Dellagostin OA; Burattini MN; Victora GD; Menezes AMB; Barros FC; Barros AJD; Victora CG
    Lancet Glob Health; 2020 Nov; 8(11):e1390-e1398. PubMed ID: 32979314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of antibody response in kidney transplant recipients and healthcare workers who had PCR-confirmed COVID-19 infection.
    Dincer MT; Eren N; Murt A; Yıldız N; Özcan ŞG; Ergül M; Bek SG; Atlı Z; Trabulus S; Dervişoğlu E; Doğanay HL; Seyahi N
    Turk J Med Sci; 2022 Dec; 52(6):1754-1761. PubMed ID: 36945967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-Cov-2 Seroprevalence in a French Kidney Transplant Center Located Within a "High-risk" Zone.
    Caillard S; Benotmane I; Meidinger C; Jegou V; Ludwiller S; Rihon A; Desmarquets A; Steinmetz L; Morvan M; Kedjam K; Bigot A; Roy D; Schmitt D; Marx D; Bassand X; Perrin P; Gautier Vargas G; Cognard N; Olagne J; Braun L; Heibel F; Martzloff J; Moulin B; Fafi Kremer S
    Transplantation; 2021 Oct; 105(10):2165-2169. PubMed ID: 33756547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.
    Charlton CL; Nguyen LT; Bailey A; Fenton J; Plitt SS; Marohn C; Lau C; Hinshaw D; Lutsiak C; Simmonds K; Kanji JN; Zelyas N; Lee N; Mengel M; Tipples G
    Microbiol Spectr; 2021 Sep; 9(1):e0029121. PubMed ID: 34406813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High SARS-CoV-2 seroprevalence in persons experiencing homelessness and shelter workers from a day-shelter in São Paulo, Brazil.
    do Couto AC; Kmetiuk LB; Delai RR; Brandão APD; Monteiro CO; da Silva LHA; Soares C; Banari AC; Bach RVW; Pettan-Brewer C; Dos Santos AP; Guimarães AMS; Oliveira DBL; Durigon EL; Biondo AW
    PLoS Negl Trop Dis; 2021 Oct; 15(10):e0009754. PubMed ID: 34665803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence and factors associated with SARS-CoV-2 infection among education workers after the first wave: the first cross-sectional study in Brazil.
    França PC; Silva PGB; Rocha JLC; Perdigão ACB; Oliveira NS; Araújo FMC; Fonseca MHG; Lima GRP; Almeida MM; Alencar CH; Oliveira WK; Cavalcanti LPG
    Rev Soc Bras Med Trop; 2022; 55():e06062021. PubMed ID: 35522813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: a prospective cohort study.
    Rozen-Zvi B; Yahav D; Agur T; Zingerman B; Ben-Zvi H; Atamna A; Tau N; Mashraki T; Nesher E; Rahamimov R
    Clin Microbiol Infect; 2021 Aug; 27(8):1173.e1-1173.e4. PubMed ID: 33957273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
    Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS
    JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 seroprevalence in the city of Puerto Madryn: Underdiagnosis and relevance of children in the pandemic.
    Schonfeld D; Fernández H; Ramírez J; Acosta D; Becerra J; Wettstein M; Strella T; Vaccaro M; Arias S; Rodríguez Calvo V; Neme R; Pérez-Chada D
    PLoS One; 2022; 17(3):e0263679. PubMed ID: 35286328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.